SciELO - Scientific Electronic Library Online

 
vol.10 issue1Changes in coronary heart disease in women one year after author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Ene

On-line version ISSN 1988-348X

Abstract

LOPEZ VALERO, Raquel; LOPEZ VALERO, Manuel  and  PULIDO SANCHEZ, María Dolores. Patient Safety E.I.M.I treated in a UCCyU: implementation of NANDA-NOC-NIC. Ene. [online]. 2016, vol.10, n.1. ISSN 1988-348X.

Or REMICADE® infliximab is a chimeric monoclonal antibody, used to reduce the inflammatory cascade in inflammatory diseases. The objectives of this research is to standardize clinical practice in patients treated with infliximab, decrease variability of care and improve the safety of these patients. It made a record of nursing diagnoses, NOC and NIC with the highest incidence seen in patients treated with E.I.M.I Inflixibab, with which you can perform nursing care quality, achieving the record and ensure proper transmission of information on care.

Keywords : Inflammation; Diagnosis; Equipment Safety; Quality of Health Care.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License